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coln Marsh (38/81, 46%). The number 
of latrines per backyard ranged from 1 
to 6 (χ = 2.15). B. procyonis eggs were 
found at 14/61 latrines sampled (23%; 
95% CI 12%–34%), and no significant 
difference  in  prevalence  was  found 
between the Ned Brown (6/23, 26%; 
95% CI 8%–44%) and Lincoln Marsh 
areas (8/38, 21%; 95% CI 8%–34%).
Evaluation  of  the  main  effect 
model  identified  a  decreasing  prob-
ability of latrine occurrence with in-
creasing  distance  from  the  nearest 
forested area and the presence of an 
outdoor pet, although these relation-
ships were only marginally significant 
(p = 0.07 and 0.08, respectively). No 
other variables were closely associated 
with the presence of raccoon latrines 
(p>0.20). When evaluated alone, dis-
tance from the forest preserve was sig-
nificantly related to latrine occurrence 
(p = 0.03); probability decreased with 
increasing distance. Evaluation of the 
simplified model identified a weakly 
positive  association  with  the  pres-
ence of a food source (p = 0.09) and 
no  association  with  the  presence  of 
latrine substrate (p = 0.35). Although 
the findings were not statistically sig-
nificant, raccoon latrines did appear to 
be associated with the availability of 
a food source such as bird feed (odds 
ratio [OR] 1.9, 95% CI 0.9–4.1); the 
presence of an outdoor pet (OR 0.27, 
95% CI 0.06–1.2) and increasing dis-
tance  from  the  nearest  forested  area 
reduced the likelihood of latrines. No 
other variables were associated with 
the presence of raccoon latrines; how-
ever, low statistical power may have 
precluded adequate assessment.
Our results suggest that when hu-
mans  live  close  to  protected  forests 
or natural areas, they are more likely 
to attract raccoons into their yards. In 
addition, anthropogenic food sources 
such  as  pet  food,  garbage,  and  bird 
feed may increase the likelihood that 
a raccoon will create a latrine, and the 
presence of outdoor pets appears to be 
a deterrent. In areas of high raccoon 
density, these attractants should be re-
moved. Homeowners with small chil-
dren should remove latrines as quickly 
as  they  are  discovered  (2). The  risk 
of  children  acquiring  potentially  fa-
tal baylisascariasis can be reduced if 
parents understand how to reduce the 
likelihood that children will come into 
contact with raccoon latrines.  
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Reemergence of 
Strongyloidiasis, 
Northern Italy
To  the  Editor:  Strongyloidi-
asis is a helminth infection caused by 
Strongyloides stercoralis, a nematode 
ubiquitous in tropical and subtropical 
countries and occasionally reported in 
temperate  countries,  including  Italy 
(1). Sources of infection are filariform 
strongyloid larvae present in soil con-
taminated by infected feces; the larvae 
penetrate through the skin of a human 
host. After the first life cycle, a process 
of autoinfection begins, which persists 
indefinitely in the host if the infection 
is not effectively treated. The infec-
tion can remain totally asymptomatic 
for many years or forever or cause cu-
taneous (itching and rash), abdominal 
(epigastric  pain,  pseudoappendicitis, 
diarrhea),  respiratory  (cough,  recur-
rent  asthma),  and  systemic  (weight 
loss, cachexia) symptoms that can be 
enervating.  More  importantly,  when 
host immunity is impaired because of 
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a concurrent disease or immunosup-
pressive  therapy  (including  corticos-
teroids, sometimes used to treat symp-
toms  of  the  unrecognized  infection 
or  the  concurrent  eosinophilia),  dis-
seminated strongyloidiasis may occur 
(2–4), causing a massive and almost 
invariably fatal invasion of virtually all 
organs and tissues by filariform larvae 
and even adult worms (Figure), often 
combined  with  bacterial  superinfec-
tion. This complication is believed to 
be rare but is probably underestimated 
because of the extreme variability of 
the clinical presentation.
Although strongyloidiasis can be 
suspected in the presence of symptoms 
or eosinophilia (which is frequent but 
not mandatory), the low sensitivity of 
direct diagnostic methods often lets 
the  disease  go  unrecognized  (5–7). 
By far the most sensitive diagnostic 
tools  are  serologic  tests:  sensitivity 
and specificity of indirect fluorescent 
antibody  test  (IFAT)  (in-house  pro-
duced IFAT) are 97.4% and 97.9%, 
respectively, at a dilution >1/20, and 
70.5% and 99.8% at a dilution >1/80 
(6). A suspected case is defined by a 
positive antibody titer >20 (IFAT); a 
case is confirmed by a positive direct 
test result (culture in agar being the 
most  sensitive  direct  technique)  or 
by a positive antibody titer >80 (6). 
Despite  some  anecdotal  reports  on 
the  presence  of  strongyloidiasis  in 
Italy (1,6), reliable information about 
the real prevalence of the infection is 
lacking. After seeing several patients 
affected by the disease, 1 of whom 
died  because  of  dissemination  (Z. 
Bisoffi, unpub. data), we decided to 
carry out a preliminary rapid assess-
ment of the extent of the problem in 
elderly patients with eosinophilia.
During  a  4-month  period,  from 
February  through  May  2008,  every 
patient  born  in  1940  or  earlier  who 
came to the clinical laboratories of 2 
contiguous health districts in northern 
Italy  (Mantova,  Lombardy  Region, 
and  Legnago,  Veneto  Region)  for  a 
diagnostic blood test (hematocrit and 
leukocyte  count/formula)  for  what-
ever reason and having a eosinophil 
count >500 cells/μL was asked to join 
the  study.  This  study  was  the  pilot 
phase of a larger, multicentered study, 
which obtained formal approval from 
the Ethical Committee of Sacro Cuore 
Hospital of Negrar, Verona. Informed 
consent was required of each patient. 
Of the 132 patients eligible for inclu-
sion (mean age 76.4 years, range 68–
90 years, male:female ratio 1.6), none 
refused to give informed consent. Se-
rum specimens were subjected to the 
IFAT  for  S.  stercoralis  at  the  Sacro 
Cuore  Hospital  Centre  for  Tropical 
Diseases.
Unexpectedly, we found that 37 
(28%) of 132 patients were positive, 
with  titers  ranging  between  20  and 
>320 (and >80 in most cases). How-
ever,  caution  should  be  exercised 
in  interpreting  the  results  because 
the  patients  may  not  be  representa-
tive of the general population. More-
over, our results are based on an in-
direct (although highly sensitive and 
specific)  test.  Because  the  reported   
cases involve only a few patients every 
year (of whom some are anecdotally 
reported as dying from the infection, 
usually unpublished), we suspect that 
most  strongyloidiasis  cases  remain 
undetected.
If relevant transmission still ex-
ists in the area, it is unknown but is 
unlikely because of the improvement 
of  hygienic  conditions  in  the  past 
5  decades.  Reports  of  the  infection 
in  children  or  young  adults  with  no 
travel  history  outside  Italy  are  lack-
ing. Strongyloidiasis in the elderly is 
therefore most likely to result from an 
infection  that  occurred  much  earlier 
in life, either in infancy or at a young 
age, while walking or working bare-
foot  in  agricultural  fields.  The  long 
persistence is the consequence of the 
autoinfection cycle typical of this par-
asite as described above. The result is 
an important and unrecognized public 
health problem affecting the geriatric 
population  of  northern  Italy.  These 
preliminary results confirm the need 
for the already planned, multicentered 
study involving a larger sample and a 
wider geographic area. 
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Figure.	Adult	female	of	Strongyloides stercoralis	collected	in	bronchial	fluid	of	a	patient	with	
disseminated	disease.	Scale	bar	=	400	µm.	A	color	version	of	this	figure	is	available	online	
(www.cdc.gov/EID/content/15/9/1531-F.htm).LETTERS
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Salmonella  
enterica Serovar 
Typhi with CTX-M 
β-Lactamase,  
Germany 
To  the  Editor:  Infection  with 
Salmonella enterica serovar Typhi, the 
causative agent of typhoid fever, is an 
acute systemic illness with a high pro-
portion of illness and deaths, especial-
ly in developing countries. In Europe, 
S. enterica ser. Typhi infections occur 
among  travelers  returning  from  dis-
ease-endemic areas. After emergence 
of multidrug-resistant S. enterica ser. 
Typhi strains that confer resistance to 
chloramphenicol,  trimethoprim,  and 
ampicillin,  quinolones  have  become 
the  primary  drugs  for  treatment  (1). 
Here we report the isolation of CTX-
M–producing S. enterica ser. Typhi in 
Germany.
We isolated S. enterica ser. Typhi 
from blood and feces specimens from 
a 30-year-old Iraqi woman who was 
admitted  to  the  hospital  in  Cologne 
in August 2008. The patient was fe-
brile,  dizzy,  and  had  epigastric  pain 
and  headache. The  symptoms  began 
2 weeks earlier, after she had returned 
from a month-long visit to her rela-
tives  in  Sulaymaniya,  the  capital  of 
As Sulaymaniyah Governorate in the 
northeastern  Iraqi  Kurdistan  region. 
The interview indicated that the same 
symptoms  had  developed  in  other 
family members in Iraq. The patient 
was  treated  successfully  with  mero-
penem (1 g 3×/day) for 2 weeks, and 
no relapse was observed in a follow-
up period of 6 months.
The  isolated  strain  was  identi-
fied as S. enterica ser. Typhi with the 
VITEK2  system  (VITEK2  GN-card; 
bioMérieux,  Brussels,  Belgium)  and 
by slide agglutination with Salmonel-
la  antisera  (SIFIN,  Berlin,  Germany) 
in  accordance  with  the  Kauffmann-
White  scheme.  By  using  Vi-phage 
typing  according  to  the  International 
Federation  for  Enteric  Phage  Typing 
(L.R.  Ward,  pers.  comm.),  the  strain 
was classified as S. enterica ser. Typhi 
Vi-phage type E9. Antimicrobial drug 
susceptibilities  were  determined  ac-
cording to the guidelines of the Clini-
cal Laboratory Standards Institute with 
the VITEK2 AST-N021 card and Etest 
(bioMérieux). The extended-spectrum 
β-lactamase  (ESBL)  phenotype  was 
confirmed with a combined disk diffu-
sion test (MASTDISCS ID, Mast Diag-
nostica GmbH, Germany). PCR and se-
quence analyses were performed with 
universal primers for the ESBL genes 
blaCTX-M, blaTEM, and blaSHV as described 
previously (2). Primer CTX-M-F 5′-G 
TTCGTCTCTTCCAGAATAAGG-3′ 
and  primer  CTX-M-R  5’-CAG-
CACTTTTGCCGTCTAAG-3′  were   
used for sequencing the entire blaCTX-M 
gene. Investigation of the CTX-M en-
vironment was performed with prim-
ers IS26-F (5′-GCCCTGGTAAGCAG 
AGTTTTTG-3′)  and  IS26-CTX-R   
(5′-ACAGCGGCACACTTCCTAA 
C-3′). The presence of plasmid-medi-
ated quinolone resistance genes (qnr) 
was determined by PCR and sequenc-
ing  of  qnrB ( 3),  qnrS  (primer  F,  5′-
CGGCACCACAACTTTTCAC-3′; 
primer  R,  5′-CAACAATACCCAGT 
GCTTCG-3′), and qnrA (primer F, 5′-
ATTTCTCACGCCAGGATTTG-3′; 
primer R, 5′-CGGCAAAGGTTAGGT 
CACAG-3′). In addition, the nucleotide 
sequences of the quinolone resistance-
determining regions of the gyrA, gyrB, 
parC, and parE genes were determined 
as previously described (4). Transfer of 
β-lactam resistance was tested by broth 
mating  assays  with  a  sodium  azide–
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